Classifying Medical Devices, The De Novo Process and the FDA's Final Rule to Simplify Medical Device Classification Procedures

Duration: 60 Minutes
This webinar will review the Medical Device Classification Procedures which includes the De Novo process in conjunction with the recent changes to 21 CFR 860 that pertain to the reclassification of the post amendment devices and the De Novo process in general.
Medical Device Classification Procedures
Instructor: Charles H Paul
Product ID: 506011
Objectives of the Presentation
At the completion of this webinar, participants will be able to:
  • Describe the De Novo Classification Process
  • Explain when the De Novo Process may be used
  • Describe the process for submitting a De Novo Request for FDA Review
  • Describe each step of the review Process for De Novo Requests
  • Explain the implications of the 21 CFR 860 regulation changes to the De Novo process
Why Should you Attend
The De Novo process is a complex process that has significant implications for the manufacturer of post amendment devices in terms of how their devices are classified. In addition, the FDA has recently revised the regulations in 21 CFR part 860 that pertain to the reclassification of devices in this category. This webinar will be essential in your continued understanding of this process and in your compliance with the new regulation changes.

Who will Benefit
  • Regulatory Affairs/Compliance
  • Quality
  • R & D
  • Engineering
  • Quality Engineers
  • Quality Managers
  • Regulatory Specialists
  • Regulatory Managers
  • Compliance Specialists
  • Design and development engineers
  • Industrial designers
  • Risk managers and project managers
  • Medical device manufacturers
  • Marketing
  • CEOs and operations managers for small companies
  • Training associates
  • Training developers
  • Training managers and directors
  • Compliance managers
  • Compliance directors
Topic Background
Unlike other countries in the world, the US uses a predicate-based system to classify its medical devices. For devices that have a predicate device in the marketplace the classification process is quite straightforward.

A predicate device is a legally marketed device, called a preamendments device, that was legally marketed prior to May 28, 1976, a device which has been reclassified from Class III to Class II or I, a device which has been found to be substantially equivalent to such a device through the 510(k) process, or one established through Evaluation of Automatic Class III Definition. The legally marketed device(s) to which equivalence is drawn is known as the "predicate" device(s).

Alternatively, devices of a new type that the FDA has not previously classified based on risk are "automatically" classified into class III regardless of the level of risk they pose. This is because, by definition, a new type of device would not be within a type that was on the market before the 1976 Medical Device Amendments or that has since been classified into Class I or Class II.

For devices that are innovative, when a predicate is found not to exist, The De Novo classification process, also known as "Evaluation of Automatic Class III Designation," is a device classification process that provides a pathway to either a Class I or Class II classification for medical devices for which general controls or general and special controls provide a reasonable assurance of safety and effectiveness, but for which there is no legally marketed predicate device.
$200
Recorded Session for one participant
Get life time access with download option!
Book this course
Pay Now
  $250.00 Training CD
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
  $300.00 Training USB Flash Drive
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
For multiple location please contact our customer care team +1-510-857-5896.
How it works
Live Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • The webinar joining link, username and password for joining the webinar will be updated on your OCP Account 24 hours prior to the webinar
  • Presentation handouts in Downloadable PDF format will be updated on your OCP Account 24 hours prior to the live session
  • Login to the audio conference on the scheduled date and time
  • Get answers to your queries through interactive Q&A sessions via chat at the end of the session
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account 24 hours after the completion of the session
  • Please let us know your thoughts and views at the end of the webinar, your valuable feedback will help us improve
Recorded Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • Upon purchase of the recorded session a link will be updated on your OCP Account within 24 hours
  • Please click on the link to access the Recorded Session
  • Presentation handouts in downloadable PDF format will be updated on your OCP Account within 24 hours of the purchase of the product
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account after 48 hours of the product Purchase
  • Please share your valuable Feedback at the end of the session
Instructor Profile:
Charles H. Paul is the President of C. H. Paul Consulting, Inc. - a regulatory, Lean Manufacturing, training, and technical documentation consulting firm. Charles is a management consultant, instructional designer and regulatory consultant and has led C. H. Paul Consulting, Inc. since its inception over 25 years ago. He regularly consults with Fortune 500 pharmaceutical, medical device, and biotechnology firms assisting them in achieving human resource, regulatory, and operational excellence. He is a regular presenter of webinars and on-site seminars in a variety of related subjects from documentation development to establishing compliant preventive maintenance systems. The firm works globally completing projects throughout the EU, UK, South America, and Asia.
View More